Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status.
Rüschoff J, Friedrich M, Nagelmeier I, Kirchner M, Andresen LM, Salomon K, Portier B, Sredni ST, Schildhaus HU, Jasani B, Grzelinski M, Viale G. Rüschoff J, et al. Among authors: portier b. Virchows Arch. 2022 Nov;481(5):685-694. doi: 10.1007/s00428-022-03378-5. Epub 2022 Aug 16. Virchows Arch. 2022. PMID: 35970977 Free PMC article.
Neoplastic Cellularity Assessment in Molecular Testing.
Devereaux KA, Souers RJ, Graham RP, Portier BP, Surrey LF, Yemelyanova A, Vasalos P, Trembath DG, Moncur JT. Devereaux KA, et al. Among authors: portier bp. Arch Pathol Lab Med. 2022 Sep 1;146(9):1062-1071. doi: 10.5858/arpa.2021-0166-CP. Arch Pathol Lab Med. 2022. PMID: 35089997 Free article.
Immunohistochemical Validation of Rare Tissues and Antigens With Low Frequency of Occurrence: Recommendations From The Anatomic Pathology Patient Interest Association (APPIA).
Lott RL, Riccelli PV, Sheppard EA, Wharton KA Jr, Walk EE, Kennedy G, Portier B. Lott RL, et al. Among authors: portier b. Appl Immunohistochem Mol Morphol. 2021 May-Jun 01;29(5):327-334. doi: 10.1097/PAI.0000000000000821. Appl Immunohistochem Mol Morphol. 2021. PMID: 32324630 Free PMC article.
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.
Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Merker JD, et al. Among authors: portier bp. Arch Pathol Lab Med. 2019 Apr;143(4):463-471. doi: 10.5858/arpa.2018-0336-CP. Epub 2018 Oct 30. Arch Pathol Lab Med. 2019. PMID: 30376374 Free PMC article.
Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers.
Barnes M, Srinivas C, Bai I, Frederick J, Liu W, Sarkar A, Wang X, Nie Y, Portier B, Kapadia M, Sertel O, Little E, Sabata B, Ranger-Moore J. Barnes M, et al. Among authors: portier b. Lab Invest. 2017 Dec;97(12):1508-1515. doi: 10.1038/labinvest.2017.82. Epub 2017 Aug 14. Lab Invest. 2017. PMID: 28805805 Free article.
Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer.
Donaldson AR, Shetty S, Wang Z, Rivera CL, Portier BP, Budd GT, Downs-Kelly E, Lanigan CP, Calhoun BC. Donaldson AR, et al. Among authors: portier bp. Cancer. 2017 Jun 15;123(12):2230-2239. doi: 10.1002/cncr.30592. Epub 2017 Feb 13. Cancer. 2017. PMID: 28192599 Free article.
43 results